CEACAM5 and non-small cell lung carcinoma: First, the patient had an initial good PS and did not develop brain metastasis, which are predictors of long-term survival in advanced NSCLC.[3,4] Second, significant reductions in serum CEA levels after initiating treatment may predict longer overall survival.[5] In our case, the serum CEA level changed significantly with progression and reflected the response to therapy.